PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...

Preparing for a PET scan requires switching to a no-sugar diet the day before the scan. People with diabetes may have special instructions regarding medications. Doctors typically schedule PET scans ...

PET scans can detect amyloid plaques and tau tangles in the brain, which are often early signs of Alzheimer’s disease. But they’re not enough on their own to make a diagnosis. Alzheimer’s disease is ...

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

PET scans may serve as both a diagnostic and prognostic tool in giant cell arteritis (GCA), according to a new study. In over 100 patients with GCA who underwent 18 F-fluorodeoxyglucose (FDG) PET ...

Advances in Total-Body PET/CT Research. Journal of Biosciences and Medicines, 14, 274-282. doi: 10.4236/jbm.2026.141021 . PET ...

Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of The ...

Medicare Part B covers outpatient PET scans when ordered by a doctor and considered medically necessary. PET scan costs can vary depending on whether you have the scan in a hospital as an inpatient, ...

A positron emission tomography (PET) scan is a diagnostic tool that examines body tissue functioning, such as blood flow, oxygen use, and sugar metabolism, to help doctors diagnose and treat disease.

Five out of six patients in FDA authorized Expanded Access Program are showing a qualitative reduction in microglia activation (a key biomarker being observed) Foralumab to advance into Phase 2 human ...